These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 8380135)
1. Innovations in multimodality therapy for lung cancer. Combined modality management of limited small-cell lung cancer. Turrisi AT Chest; 1993 Jan; 103(1 Suppl):56S-59S. PubMed ID: 8380135 [TBL] [Abstract][Full Text] [Related]
2. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group. Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106 [TBL] [Abstract][Full Text] [Related]
3. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. Turrisi AT; Kim K; Blum R; Sause WT; Livingston RB; Komaki R; Wagner H; Aisner S; Johnson DH N Engl J Med; 1999 Jan; 340(4):265-71. PubMed ID: 9920950 [TBL] [Abstract][Full Text] [Related]
4. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial. Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596 [TBL] [Abstract][Full Text] [Related]
5. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Komaki R; Shin DM; Glisson BS; Fossella FV; Murphy WK; Garden AS; Oswald MJ; Hong WK; Roth JA; Peters LJ Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):807-11. PubMed ID: 7860392 [TBL] [Abstract][Full Text] [Related]
7. Limited small cell lung cancer--the role of radiotherapy. Turrisi AT Oncology (Williston Park); 1988 Jul; 2(7):19-25, 28-9, 32. PubMed ID: 2856316 [TBL] [Abstract][Full Text] [Related]
8. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer. Kamath SS; McCarley DL; Zlotecki RA Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169 [TBL] [Abstract][Full Text] [Related]
9. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy]. Payne DG; Murray N; Warde P Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Schild SE; Bonner JA; Shanahan TG; Brooks BJ; Marks RS; Geyer SM; Hillman SL; Farr GH; Tazelaar HD; Krook JE; Geoffroy FJ; Salim M; Arusell RM; Mailliard JA; Schaefer PL; Jett JR Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):943-51. PubMed ID: 15234027 [TBL] [Abstract][Full Text] [Related]
11. Combined chemoradiation therapy for limited-stage small-cell lung cancer. Teng M; Choy H; Ettinger D Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):107-15. PubMed ID: 10550834 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin-etoposide based chemoradiation treatment for limited small cell lung cancer: the current situation. Turrisi AT Anticancer Res; 1994; 14(1B):289-93. PubMed ID: 8166469 [TBL] [Abstract][Full Text] [Related]
13. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW; J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930 [TBL] [Abstract][Full Text] [Related]
14. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK; J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033 [TBL] [Abstract][Full Text] [Related]
15. Concurrent versus sequential radiotherapy for small cell lung cancer. Tsukada H; Yokoyama A; Goto K; Takada M; Saijo N; Semin Oncol; 2001 Apr; 28(2 Suppl 4):23-6. PubMed ID: 11479893 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of small cell lung cancer: limited diseases. Guidelines of clinical practice made by the European Lung Cancer Working Party]. European Lung Cancer Working Party Rev Med Brux; 2008; 29(3):159-67. PubMed ID: 18705597 [TBL] [Abstract][Full Text] [Related]
17. Radiation therapy in the management of limited small cell lung cancer: when, where, and how much? Wagner H Chest; 1998 Jan; 113(1 Suppl):92S-100S. PubMed ID: 9438697 [TBL] [Abstract][Full Text] [Related]
18. [Multimodality therapy for small-cell lung cancer]. Yokoyama A Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():405-11. PubMed ID: 9369915 [TBL] [Abstract][Full Text] [Related]
19. [Early irradiation with radiochemotherapy for limited-stage small cell lung cancer is superior to late irradiation]. Fietkau R; Sauer R Strahlenther Onkol; 2002 Nov; 178(11):585-8. PubMed ID: 12518770 [No Abstract] [Full Text] [Related]